WHITTIER TRUST CO - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 116 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
WHITTIER TRUST CO ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$2,494
-16.6%
2890.0%0.00%
Q2 2023$2,991
-4.6%
2890.0%0.00%
Q1 2023$3,135
-3.3%
2890.0%0.00%
Q4 2022$3,242
+8.1%
2890.0%0.00%
Q3 2022$3,0000.0%2890.0%0.00%
Q2 2022$3,0000.0%2890.0%0.00%
Q1 2022$3,0000.0%2890.0%0.00%
Q4 2021$3,000
+50.0%
2890.0%0.00%
Q3 2021$2,000
-50.0%
2890.0%0.00%
Q2 2021$4,000
-33.3%
2890.0%0.00%
Q1 2021$6,000
+20.0%
2890.0%0.00%
Q4 2020$5,000
+25.0%
2890.0%0.00%
Q3 2020$4,000
-33.3%
2890.0%0.00%
Q2 2020$6,000
-14.3%
2890.0%0.00%
Q1 2020$7,0000.0%2890.0%0.00%
Q4 2019$7,000
+16.7%
2890.0%0.00%
Q3 2019$6,000
+20.0%
2890.0%0.00%
Q2 2019$5,000
-54.5%
289
-40.3%
0.00%
Q1 2019$11,000
-8.3%
4840.0%0.00%
Q4 2018$12,000
-25.0%
4840.0%0.00%
Q3 2018$16,000
+45.5%
4840.0%0.00%
Q2 2018$11,000
-8.3%
4840.0%0.00%
Q1 2018$12,0004840.00%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Woodford Investment Management Ltd 10,898,879$264,297,00023.51%
Foundation Asset Management, LP 399,537$9,689,0003.59%
Cormorant Asset Management, LP 1,300,000$31,525,0002.35%
Baupost Group 9,309,168$225,747,0002.18%
Old West Investment Management, LLC 109,320$2,651,0001.53%
SENZAR ASSET MANAGEMENT, LLC 187,856$4,555,0001.44%
Chescapmanager LLC 350,631$8,503,0001.27%
Virtus ETF Advisers LLC 32,989$800,0000.69%
Rock Springs Capital Management LP 652,600$15,826,0000.68%
NJ State Employees Deferred Compensation Plan 34,142$828,0000.15%
View complete list of THERAVANCE BIOPHARMA INC shareholders